Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Ondra Health vs FMmeds

Two GLP-1 deals, scored on the same six factors. Ondra Health lands a Value Score of 92, FMmeds a 76. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Ondra Health

#2 · Grade A+ · Best Value

Est. first month

$93/mo

Save ~93% vs brand-name
Get this deal Full Ondra Health review →
VS

FMmeds

#113 · Grade B- · Fair Price

Est. first month

From $225/mo (all doses, compounded)

Save ~83% vs brand-name
Get this deal Full FMmeds review →

The verdict

Better value: Ondra Health

Ondra Health takes it on Value Score, 92 to 76 an est. $93/mo first month, with no teaser step-up baked in. FMmeds isn't out of it: Shoppers who want flat-rate compounded GLP-1 co-formulated with vitamin B12, from $95/mo.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealOndra HealthFMmeds
Value Score92 (A+)76 (B-)
Est. first month$93/moFrom $225/mo (all doses, compounded)
Save vs brand-name~93%~83%
Semaglutide$93/moFrom $225/mo (all doses, compounded)
Tirzepatide$166/moFrom $265/mo (all doses, compounded)
Both moleculesYesYes
PricingFlat — no step-upFlat — no step-up
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

96
Lowest Real Price
67
Ondra Health: 96. FMmeds: 67.
88
No Teaser-Rate Bait
90
Ondra Health: 88. FMmeds: 90.
98
Nationwide Availability
96
Ondra Health: 98. FMmeds: 96.
92
Both Molecules
92
Ondra Health: 92. FMmeds: 92.
84
Easy Cancellation
58
Ondra Health: 84. FMmeds: 58.
84
Reputation
57
Ondra Health: 84. FMmeds: 57.

Ondra Health

The cheapest flat semaglutide sticker we track ($93) — LegitScript-certified, all 50 states, and it still offers brand-name access.

Why it's a deal

  • Lowest disclosed flat semaglutide price in the roster ($93/mo) — no teaser step-up
  • LegitScript-certified and available in all 50 states
  • Offers FDA-approved brand-name access alongside compounded
  • Tirzepatide is competitive too at $166/mo

The fine print

  • Newer name with a shorter public track record than the established flat-fee brands
  • No oral/sublingual route for the needle-averse

FMmeds

FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.

Why it's a deal

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

The fine print

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Get the Ondra Health deal Get the FMmeds deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Ondra Health is ranked on the Ondra Health alternatives board, and the same list for the other side is on alternatives to FMmeds.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.